Sertraline in children and adolescents with social anxiety disorder: An open trial

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 40, Issue 5, 2001, Pages 564-571

  Compton, S N ^a   Grant, P J ^a   Chrisman, A K ^a   Gammon, P J ^a   Brown, V L ^a   March, J S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adolescent; Pharmacotherapy; Preadolescent; Sertraline; Social anxiety disorder

Indexed keywords

SERTRALINE;

ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; MALE; NAUSEA; OUTPATIENT; PRIORITY JOURNAL; RASH; RATING SCALE; SELF REPORT; TREATMENT OUTCOME;

EID: 0035033123     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200105000-00016     Document Type: Article

References (34)

1. Treatment of anxiety disorders of childhood
2. Sertraline treatment of children and adolescents with obsessive-compulsive disorder or depression: Pharmacokinetics, tolerability, and efficacy
3. The relationship between DSM-III symptom disorders (Axis I) and personality disorders (Axis II) in an outpatient population
4. Social phobia: A comparative clinical study
5. A new inventory to assess childhood social anxiety and phobia: The social phobia and anxiety inventory for children
6. A 3-year follow-up of children with and without behavioral inhibition
7. Fluoxetine for childhood anxiety disorders
8. Separation anxiety disorder and panic disorder
9. Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial
10. Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients
11. The revised Conners' Parent Rating Scale (CPRS-R): Factor structure, reliability, and criterion validity
12. Epidemiology
13. Fluoxetine treatment of children with selective mutism: An open trial
14. Open fluoxetine treatment of mixed anxiety disorders in children and adolescents
15. Traditional and alternative research designs and methods in clinical pediatric psychopharmacology
16. Similarities in response to fluoxetine in the treatment of children and adolescents with obsessive-compulsive disorder
17. Sertraline for social phobia: A double-blind, placebo-controlled crossover study
18. The Children's Depression Inventory (CDI)
19. Pharmacotherapy of pediatric anxiety disorders
20. DSM-III-R anxiety disorders in children: Sociodemographic and clinical characteristics
21. Ethical issues in psychopharmacology treatment research with children and adolescents
22. Reasonable expectations: From the Institute of Medicine
23. Sertraline in the treatment of panic disorder: A multi-site, double-blind, placebo-controlled, fixed-dose investigation
24. Pharmacotherapy of pediatric anxiety disorders: A critical review
25. Sertraline in children and adolescents with obsessive-compulsive disorder: A multicenter randomized controlled trial
26. Panic disorder in children at high risk for depression
27. The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders
28. Antidepressant efficacy of sertraline: A double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression
29. Social phobia: Comorbidity and morbidity in an epidemiologic sample
30. The anxiety disorders interview schedule for children
31. Medication development and testing in children and adolescents: Current problems, future directions